Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Clin Nucl Med. 2017 Oct;42(10):735–740. doi: 10.1097/RLU.0000000000001804

Figure 3.

Figure 3

Pathologically confirmed prostate tumors (outlined on the MRI-registered to PET) showed significant higher 18F-DCFBC uptake than benign prostatic hyperplasia (BPH) or normal prostate areas, at 1 hour (p=0.0033) and at 2 hours (p=0.012). p.i.